Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

New filovirus disease classification and nomenclature.

Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Pawęska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z.

Nat Rev Microbiol. 2019 May;17(5):261-263. doi: 10.1038/s41579-019-0187-4. No abstract available.

PMID:
30926957
2.

Unrecognised Ebola virus infection in contact persons: what can we learn from it?

Fletcher TE, Bower H.

Lancet Infect Dis. 2019 Mar;19(3):225-226. doi: 10.1016/S1473-3099(18)30689-3. Epub 2019 Feb 11. No abstract available.

PMID:
30765244
3.

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection.

O'Shea MK, Fletcher TE, Muller J, Tanner R, Matsumiya M, Bailey JW, Jones J, Smith SG, Koh G, Horsnell WG, Beeching NJ, Dunbar J, Wilson D, Cunningham AF, McShane H.

Front Immunol. 2018 Dec 14;9:2893. doi: 10.3389/fimmu.2018.02893. eCollection 2018.

4.

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

O'Shea MK, Tanner R, Müller J, Harris SA, Wright D, Stockdale L, Stylianou E, Satti I, Smith SG, Dunbar J, Fletcher TE, Dedicoat M, Cunningham AF, McShane H.

Sci Rep. 2018 Sep 27;8(1):14480. doi: 10.1038/s41598-018-32755-x.

5.

Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.

Dickson SJ, Clay KA, Adam M, Ardley C, Bailey MS, Burns DS, Cox AT, Craig DG, Espina M, Ewington I, Fitchett G, Grindrod J, Hinsley DE, Horne S, Hutley E, Johnston AM, Kao RLC, Lamb LE, Lewis S, Marion D, Moore AJ, Nicholson-Roberts TC, Phillips A, Praught J, Rees PS, Schoonbaert I, Trinick T, Wilson DR, Simpson AJ, Wang D, O'Shea MK, Fletcher TE.

J Infect. 2018 Apr;76(4):383-392. doi: 10.1016/j.jinf.2017.12.006. Epub 2017 Dec 14.

6.

Reply to Steptoe et al.

Jagadesh S, Fletcher TE, Sevalie S, Weigel R, Scott JT.

Clin Infect Dis. 2018 Apr 3;66(8):1319. doi: 10.1093/cid/cix980. No abstract available.

PMID:
29126296
7.

Evidence-based guidelines for supportive care of patients with Ebola virus disease.

Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA 2nd, Fletcher TE, Levine AC, Reed P, Bausch DG, Gove S, Hall A, Shepherd S, Siemieniuk RA, Lamah MC, Kamara R, Nakyeyune P, Soka MJ, Edwin A, Hazzan AA, Jacob ST, Elkarsany MM, Adachi T, Benhadj L, Clément C, Crozier I, Garcia A, Hoffman SJ, Guyatt GH.

Lancet. 2018 Feb 17;391(10121):700-708. doi: 10.1016/S0140-6736(17)31795-6. Epub 2017 Oct 17.

PMID:
29054555
8.

Disability Among Ebola Survivors and Their Close Contacts in Sierra Leone: A Retrospective Case-Controlled Cohort Study.

Jagadesh S, Sevalie S, Fatoma R, Sesay F, Sahr F, Faragher B, Semple MG, Fletcher TE, Weigel R, Scott JT.

Clin Infect Dis. 2018 Jan 6;66(1):131-133. doi: 10.1093/cid/cix705.

9.

Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.

Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader Ç, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H.

PLoS One. 2017 Sep 8;12(9):e0182315. doi: 10.1371/journal.pone.0182315. eCollection 2017.

10.

Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut.

Carroll MW, Haldenby S, Rickett NY, Pályi B, Garcia-Dorival I, Liu X, Barker G, Bore JA, Koundouno FR, Williamson ED, Laws TR, Kerber R, Sissoko D, Magyar N, Di Caro A, Biava M, Fletcher TE, Sprecher A, Ng LFP, Rénia L, Magassouba N, Günther S, Wölfel R, Stoecker K, Matthews DA, Hiscox JA.

mSphere. 2017 Aug 23;2(4). pii: e00325-17. doi: 10.1128/mSphereDirect.00325-17. eCollection 2017 Jul-Aug.

11.

Knowledge, attitudes and practice for Ebola virus disease in the national rapidly deployable isolation and treatment facility in Sierra Leone.

Reidy P, Wurie A, Barnes W, Carr E, Kamau D, Marsden D, Mundell K, Watson L, Paveley M, Sithole BL, Sekikongo TM, Johnston AM, Fletcher TE.

J Infect. 2017 Jun;74(6):618-620. doi: 10.1016/j.jinf.2017.03.009. Epub 2017 Mar 24. No abstract available.

PMID:
28347706
12.

Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey.

Pshenichnaya NY, Leblebicioglu H, Bozkurt I, Sannikova IV, Abuova GN, Zhuravlev AS, Barut S, Shermetova MB, Fletcher TE.

Int J Infect Dis. 2017 May;58:58-64. doi: 10.1016/j.ijid.2017.02.019. Epub 2017 Feb 27. Review.

13.

Trial of ZMapp for Ebola Virus Infection.

Jacob ShT, Fletcher TE.

N Engl J Med. 2017 Feb 16;376(7):700. No abstract available.

PMID:
28207206
14.

Aetiology of PCR negative suspected Crimean-Congo hemorrhagic fever cases in an endemic area.

Tanyel E, Sunbul M, Fletcher TE, Leblebicioglu H.

Pathog Glob Health. 2016 Jun-Jul;110(4-5):173-7. doi: 10.1080/20477724.2016.1213958.

15.

Ebola virus disease and critical illness.

Leligdowicz A, Fischer WA 2nd, Uyeki TM, Fletcher TE, Adhikari NK, Portella G, Lamontagne F, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima E, Lamah MC, Schieffelin JS, Brett-Major D, Bausch DG, Shindo N, Chan AK, O'Dempsey T, Mishra S, Jacobs M, Dickson S, Lyon GM 3rd, Fowler RA.

Crit Care. 2016 Jul 29;20(1):217. doi: 10.1186/s13054-016-1325-2. Review.

16.

Convalescent Plasma for Ebola Virus Disease.

Fletcher TE, Fischer WA 2nd, Jacob ST.

N Engl J Med. 2016 Jun 23;374(25):2499-500. doi: 10.1056/NEJMc1602284. No abstract available.

PMID:
27332916
17.

Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever.

Guler N, Eroglu C, Yilmaz H, Karadag A, Alacam H, Sunbul M, Fletcher TE, Leblebicioglu H.

PLoS One. 2016 Jun 15;11(6):e0157247. doi: 10.1371/journal.pone.0157247. eCollection 2016.

18.

Crimean-Congo haemorrhagic fever in travellers: A systematic review.

Leblebicioglu H, Ozaras R, Fletcher TE, Beeching NJ; ESCMID Study Group for Infections in Travellers and Migrants (ESGITM).

Travel Med Infect Dis. 2016 Mar-Apr;14(2):73-80. doi: 10.1016/j.tmaid.2016.03.002. Epub 2016 Mar 10. Review.

PMID:
26970396
19.

Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study.

Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, Elaldi N, Cicek Senturk G, Ozkurt Z, Yilmaz G, Fletcher TE, Beeching NJ.

Clin Microbiol Infect. 2016 Apr;22(4):387.e1-387.e4. doi: 10.1016/j.cmi.2015.11.024. Epub 2016 Jan 20.

20.

A fatal case of healthcare associated Crimean-Congo haemorrhagic fever with severe disease and multi-organ failure.

Sunbul M, Esen S, Fletcher TE, Dilek A, Guler N, Beeching NJ, Leblebicioglu H.

J Infect. 2016 Feb;72(2):253-5. doi: 10.1016/j.jinf.2015.10.005. Epub 2015 Oct 19. No abstract available.

PMID:
26493271
21.

Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey.

Sunbul M, Leblebicioglu H, Fletcher TE, Elaldi N, Ozkurt Z, Bastug A, Yilmaz G, Guner R, Duygu F, Beeching NJ.

J Infect. 2015 Nov;71(5):597-9. doi: 10.1016/j.jinf.2015.07.003. Epub 2015 Jul 18. No abstract available.

PMID:
26196597
22.

Diagnosis of Febrile Illnesses Other Than Ebola Virus Disease at an Ebola Treatment Unit in Sierra Leone.

O'Shea MK, Clay KA, Craig DG, Matthews SW, Kao RL, Fletcher TE, Bailey MS, Hutley E.

Clin Infect Dis. 2015 Sep 1;61(5):795-8. doi: 10.1093/cid/civ399. Epub 2015 May 19.

PMID:
25991466
23.

Ebola worker's foot.

Caton EL, Bailey MS, Bevilacqua CA, Fletcher TE.

QJM. 2015 Oct;108(10):833. doi: 10.1093/qjmed/hcv076. Epub 2015 Apr 3. No abstract available.

PMID:
25841954
24.

Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit.

Rees PS, Lamb LE, Nicholson-Roberts TC, Ardley CN, Bailey MS, Hinsley DE, Fletcher TE, Dickson SJ.

Intensive Care Med. 2015 May;41(5):735-43. doi: 10.1007/s00134-015-3736-y. Epub 2015 Mar 12.

PMID:
25761540
25.

Being ready to treat Ebola virus disease patients.

Brett-Major DM, Jacob ST, Jacquerioz FA, Risi GF, Fischer WA, Kato Y, Houlihan CF, Crozier I, Bosa HK, Lawler JV, Adachi T, Hurley SK, Berry LE, Carlson JC, Button TC, McLellan SL, Shea BJ, Kuniyoshi GG, Ferri M, Murthy SG, Petrosillo N, Lamontagne F, Porembka DT, Schieffelin JS, Rubinson L, O'Dempsey T, Donovan SM, Bausch DG, Fowler RA, Fletcher TE.

Am J Trop Med Hyg. 2015 Feb;92(2):233-237. doi: 10.4269/ajtmh.14-0746. Epub 2014 Dec 15.

26.

Understanding organ dysfunction in Ebola virus disease.

Fletcher TE, Fowler RA, Beeching NJ.

Intensive Care Med. 2014 Dec;40(12):1936-9. doi: 10.1007/s00134-014-3515-1. Epub 2014 Nov 1. No abstract available.

PMID:
25366120
27.

Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF; KGH Lassa Fever Program; Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team.

N Engl J Med. 2014 Nov 27;371(22):2092-100. doi: 10.1056/NEJMoa1411680. Epub 2014 Oct 29.

28.

Ebola and other viral haemorrhagic fevers.

Fletcher TE, Brooks TJ, Beeching NJ.

BMJ. 2014 Aug 11;349:g5079. doi: 10.1136/bmj.g5079. No abstract available.

PMID:
25113010
29.

Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.

O'Shea MK, Fletcher TE, Beeching NJ, Dedicoat M, Spence D, McShane H, Cunningham AF, Wilson D.

PLoS One. 2014 May 9;9(5):e97366. doi: 10.1371/journal.pone.0097366. eCollection 2014.

30.

Screening for latent tuberculosis and gastrointestinal parasite infections in Gurkha recruits: research driving policy change.

O'Shea MK, Fletcher TE, Tupper D, Ross D, Wilson D.

J R Army Med Corps. 2014 Jun;160(2):180-2. doi: 10.1136/jramc-2014-000259. Epub 2014 Mar 7. Review.

PMID:
24607484
31.

Deployed antimicrobial stewardship: an audit of antimicrobial use at Role 3.

Fletcher TE, Hutley E, Adcock CJ, Martin N, Wilson DR.

J R Army Med Corps. 2013 Sep;159(3):237-9. doi: 10.1136/jramc-2013-000116. Epub 2013 Jul 19.

PMID:
24109146
32.

Malaria.

Fletcher TE, Beeching NJ.

J R Army Med Corps. 2013 Sep;159(3):158-66. doi: 10.1136/jramc-2013-000112. Epub 2013 Jul 11. Review.

PMID:
24109136
33.

The benefits of an infectious disease/radiology multidisciplinary team meeting.

Fletcher TE, Ali H, Ryall C, Beeching NJ, Joekes E, Lewthwaite P.

J Infect. 2012 Oct;65(4):363-5. doi: 10.1016/j.jinf.2012.05.007. Epub 2012 May 24. No abstract available.

PMID:
22634183
34.

Travellers and viral haemorrhagic fevers: what are the risks?

Beeching NJ, Fletcher TE, Hill DR, Thomson GL.

Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S26-35. doi: 10.1016/j.ijantimicag.2010.06.017. Epub 2010 Aug 11.

PMID:
20705436
35.

Exposure of spray-men to dieldrin in residual spraying.

FLETCHER TE, PRESS JM, WILSON DB.

Bull World Health Organ. 1959;20(1):15-25.

36.

Estimation of traces of DDT using Aedes aegypti larvae as a biological indicator.

FLETCHER TE.

Trans R Soc Trop Med Hyg. 1951 Feb;44(4):364-5. No abstract available.

PMID:
14817816

Supplemental Content

Loading ...
Support Center